Transient

Beating cancer

Precision Medicines is dedicated to improving the lives of cancer patients through developing novel treatments that are targeted to genomically defined cancer sub types.

Precision co-develops targeted cancer therapies with companion biomarkers to direct treatment to those patients most likely to benefit from them.

science crop2.jpg

In-licensing therapies

Precision Medicines in-licenses oncology therapies from pharma, biotech, leading clinical and academic centres to develop alongside companion biomarkers. 

Coffee+Meeting1.jpg

Building partnerships

Precision Medicines collaborate with biotech, pharma, academic and clinical centres globally to identify and develop novel cancer therapies and companion biomarkers for development.

Healthcare-Mgmt.jpg

Expertise

Precision Medicines is led by a management team and advisors with world-renowned expertise in cancer genomics, drug discovery and development, clinical oncology, and companion biomarkers.